TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets. March 7, 2008
TCL Archive In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman January 18, 1991